Sort
15,842 grants matching “pancreatic cancer”
HTS enabled examination of drug combinations
$1,215,806Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
SBIR Phase II: nCapsule Personalized Cancer Screening for Colorectal Cancer Treatment Regimens
$1,213,619Armin T Rad · Encapsulate Llc · · FY2025 · TIP
Preclinical drug development in pancreatic cancer
$1,212,844Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
GI RESEARCH ON ABSORPTIVE &SECRETORY PROCESSES
$1,212,493Tufts Medical Center · P30 · FY2005 · DK
Tyrosine kinase receptors (VEGFR and EGFR) regulate normal automaticity of heart pacemaker, the sinoatrial node.
$1,212,420Edward Lakatta · National Institute On Aging · ZIA · FY2025 · AG
DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs
$1,211,401Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma
$1,207,024Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2013 · CA
Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center
$1,207,007Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · U54 · FY2023 · CA
Signal Transduction Events and the Regulation of Cell Growth
$1,205,526Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2022 · CA
Pancreatic Cancer ARTNet Center
$1,202,713Pankaj Kumar Singh · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2024 · CA
Photodynamic Priming of Cancer and Image-guidance for Optimal Immune Response
$1,202,445Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2023 · CA
NADPH Oxidases as Novel Targets for Cancer Therapy
$1,201,732James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
NADPH Oxidases as Novel Targets for Cancer Therapy
$1,201,276James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma
$1,201,109Randall Brand · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · CA
Signal Transduction Events and the Regulation of Cell Growth
$1,199,893Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2021 · CA
First-in-class TREM-1 inhibitors in combination therapy for pancreatic cancer
$1,198,246Alexander B Sigalov · Signablok, Inc. · R44 · FY2020 · CA
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,194,199Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Combinational Immunotherapies to Amplify Vaccine Induced
$1,193,000Johns Hopkins University · U19 · FY2005 · CA
Great Lakes/New England Clinical Epidemiology/Validation
$1,191,805University Of Michigan At Ann Arbor · U01 · FY2005 · CA
Overhauser Enhanced Magnetic Resonance Imaging (OMRI)
$1,191,129Murali Krishna · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Time Domian Electron Paramagnetic Resonance Imaging
$1,191,129Murali Krishna · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Texas Medical Center Digestive Diseases Center
$1,191,053Hashem B El-Serag · Baylor College Of Medicine · P30 · FY2023 · DK
Genomic and genetic studies of endocrine cancers
$1,189,352Electron Kebebew · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Academic-Industrial Partnership to Develop Clinical Tools for Algorithmic Irreversible Electroporation of Inoperable Tumors
$1,189,042Michael Benjamin Sano · North Carolina State University Raleigh · R01 · FY2025 · CA
Texas Medical Center Digestive Diseases Center
$1,188,057Hashem B El-Serag · Baylor College Of Medicine · P30 · FY2024 · DK